Quantcast

Latest Purdue Pharma Stories

2014-07-08 08:31:18

Anticipated FDA action set for October 2014 STAMFORD, Conn., July 8, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) has granted Priority Review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet (HYD). This investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate for the purpose of misuse or abuse by...

2014-06-18 08:29:38

Agreement renews and expands partnership to drive continued business value from infrastructure and application operations SUNNYVALE, California, June 18, 2014 /PRNewswire/ -- HCL Technologies Ltd [http://www.hcltech.com ]. (HCL), a global IT services provider, today announced that its customer, Purdue Pharma L.P [http://www.purduepharma.com ], a leading pharmaceutical company has extended its end-to-end IT Infrastructure Management engagement with HCL, marking an important...

2014-05-22 08:28:50

STAMFORD, Conn., May 22, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that Saeed Motahari has joined the company as Senior Vice President and Chief Commercial Officer. "We welcome Saeed to the Purdue team. I am confident that his impressive capabilities will strengthen our organization," said Mark Timney, President and CEO of Purdue Pharma. "Saeed's experience and expertise make him uniquely qualified to lead our commercial efforts." Saeed has more than 20 years of...

2014-04-30 08:33:23

Data from Clinical Drug-liking Studies Also to be Presented at APS Today STAMFORD, Conn., April 30, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration (FDA) seeking authorization to market a once-daily, single-entity hydrocodone bitartrate tablet (HYD). This investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate...

2014-04-29 12:33:30

STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33(rd) Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla. Following is a schedule of select poster presentations: Authors Date / Time Title...

2014-04-01 08:28:22

MONMOUTH JUNCTION, N.J., April 1, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced several key management changes, including the new appointment of Mr. Stephen J. Kovary to the position of Vice President of Operations. Mr. Kovary brings three decades of pharmaceutical experience in the areas of manufacturing, process improvement, facilities, engineering, plant and systems management. Prior to...

2014-03-12 08:30:24

Investigational Opioid Analgesic Incorporates Abuse-Deterrent Technology STAMFORD, Conn., March 12, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that a Phase 3 study of an investigational extended-release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once-daily analgesic agent experienced statistically significant reduction in pain compared with placebo (p=0.0016). This investigational...

2014-02-14 16:25:45

DUBLIN, February 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pdhgfs/pain_management) has announced the addition of the "Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/pdhgfs/pain_management ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global pain management...

2014-02-04 20:22:43

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/f3g6bf/pain_management) has announced the addition of the "Concise Analysis on the International Pain Management Treatment Markets" [http://www.researchandmarkets.com/research/f3g6bf/pain_management ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Pain management describes a particular set of drugs, analgesics, which...

2014-01-28 23:29:46

Passages Malibu CEO issues statement on the FDA Approval of Zohydro. Malibu, CA (PRWEB) January 28, 2014 The Food and Drug Administration (FDA) recently approved the sale of Zohydro ER, an extended release version of hydrocodone developed and manufactured by Zogenix. Following that approval, on December 12th 2013, attorneys general from 27 states and the US territory of Guam issued a letter, asking the FDA to reconsider its green light of the drug. A panel hired by the FDA voted 11-2...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related